Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02364154 |
Date of registration:
|
10/02/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Colorectal Cancer Detected by 1H-NMR Spectroscopy
BIOCOR |
Scientific title:
|
Metabolic Phenotyping of Blood Plasma by Means of 1H-NMR Spectroscopy: a New Tool to Detect Colorectal Cancer? |
Date of first enrolment:
|
December 2014 |
Target sample size:
|
100 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02364154 |
Study type:
|
Observational [Patient Registry] |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Belgium
| | | | | | | |
Contacts
|
Name:
|
Philip Caenepeel, prof. dr. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Ziekenhuis Oost-Limburg, Hasselt University |
|
Name:
|
Robby Louis, student |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hasselt University |
|
Name:
|
Liesbet Mesotten, prof. dr. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Ziekenhuis Oost-Limburg, Hasselt University |
|
Name:
|
Michiel thomeer, prof. dr. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Ziekenhuis Oost-Limburg, Hasselt University |
|
Name:
|
Evelyne Louis, PhD student |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hasselt University |
|
Name:
|
Kirsten Stinkens, dr. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hasselt University |
|
Name:
|
Peter Adriaensens, prof. dr. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hasselt University |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- The subject has undergone a colonoscopy or is scheduled to undergo a colonoscopy in
the future
- The subject is aged between 40 and 90 years
- The subject understands the study-specific procedures and provides written informed
consent before any study-specific procedures are performed
Exclusion Criteria:
- No fasting starting from 10 p.m. the day prior to blood sampling
- Medication intake on the morning of blood sampling
- Diabetes
- History of cancer during the past 5 years
- Treatment for cancer during the past 5 years
- Inflammatory bowel disease
Age minimum:
40 Years
Age maximum:
90 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Colorectal Cancer
|
Intervention(s)
|
Other: Blood sampling
|
Other: Control group-Blood sampling
|
Primary Outcome(s)
|
metabolic phenotype of colorectal cancer
[Time Frame: day 1]
|
Secondary Outcome(s)
|
tumor stage
[Time Frame: Day 1]
|
tumor histology
[Time Frame: day 1]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|